Position paper ANMCO in collaboration with Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P): ‘the management of hospital discharge’ Authors: Carmine Riccio, Francesco Fattirolli, Marco Ambrosetti, Giovanna Geraci, Massimo Milli, Maurizio Giuseppe Abrignani, Maria Elisabetta Angelino, Michela Barisone, Barbara Biffi, Arturo Cesaro, Maurizio de Giovanni, Stefania Angela Di Fusco, Andrea Di Lenarda, Antonio Mazza, Damiano Parretti, Donatella Radini, Matteo Ruzzolini, Simonetta Scalvini, Pietro Scicchitano, Elio Venturini, Claudio Bilato, Pasqualina Calisi, Marco Corda, Leonardo De Luca, Massimo Di Marco, Attilio Iacovoni, Francesco Maranta, Alessandro Navazio, Vittorio Pascale, Massimo Pistono, Emanuele Tizzani, Marika Werren, Michele Massimo Gulizia, Federico Nardi, Domenico Gabrielli, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva Published: 2026 ABSTRACT AbstractHospital discharge is a pivotal stage in the continuum of care, marking the transition from the acute clinical episode to subsequent therapeutic management. Rather than being a purely administrative procedure, discharge is a multifaceted process that requires structured planning, clear communication, and the coordinated participation of all healthcare stakeholders, with the patient playing a central role. Inadequate discharge processes may adversely affect clinical outcomes and increase hospital readmission rates, resulting in sub-optimal utilization of healthcare resources. This issue is particularly relevant in the context of an ageing and increasingly frail population, characterized by a high burden of comorbidities and complex clinical needs. In this setting, discharge planning should be treated as an integral component of the care pathway, embedded within a comprehensive, coordinated model of care. This document proposes an updated, practical framework for hospital discharge management, grounded in current scientific evidence and multidisciplinary expertise. Its primary objective is to enhance continuity of care, support individualized treatment strategies, and ultimately improve patient outcomes. Specifically, this paper aims to provide clinical cardiologists with a structured reference tool for discharge management, including actionable recommendations to strengthen physician–patient communication, optimize therapeutic regimens, and promote better health outcomes. Introduction Hospital discharge represents a crucial component within the continuum of care and a fundamental element of the hospital–community pathway. An appropriately structured discharge process enables patients to receive the information necessary to return home, gain awareness and reassurance, and allows primary care physicians to manage ongoing care safely and effectively. This contributes to improved therapeutic appropriateness and adherence, more rational use of healthcare resources, avoidance of unnecessary testing, and the implementation of pharmacological and non-pharmacological strategies consistent with the patient’s individual risk profile and recommended clinical targets. Discharge should not be regarded as a single moment limited to the delivery of the discharge letter. Rather, it is a process that develops throughout hospitalization and relies on effective communication. Information should be provided in a language, with timing and depth of explanation tailored to each patient's characteristics, needs, and level of understanding. The discharge letter is the primary document through which information is conveyed regarding the clinical course, the potential consequences of the acute event on daily life, and the therapeutic plan. This includes the initiation and long-term continuation of pharmacological treatment—some of which may be lifelong—together with clear recommendations on lifestyle modification. At present, no specific guidelines strictly regulate the structure of discharge letters; available recommendations mainly outline the essential elements to include. In the development of this document, consideration was also given to the areas of competence of other healthcare professionals—such as nurses, physiotherapists, psychologists, and dietitians—who, depending on the organization and resources of individual centres, contribute to the care pathway. This broader perspective allows physicians receiving the discharge letter to obtain a comprehensive, multidimensional overview, reinforcing its role as a continuity-of-care tool and a bridge between the acute phase and long-term management. Building on previous evidence,1 an update was considered appropriate in relation to the recent data concerning pharmacological therapies and post-discharge management strategies. To improve practical adoption and use, the document incorporates flowcharts and checklists. Particular attention is paid to communication strategies and the expectations and needs of both patients and general practitioners, which are key elements in constructing an effective and clinically appropriate discharge pathway. Communication strategies for ameliorating outcomes An inaccurate discharge should be regarded as a communication failure. However, this failure cannot be limited to the final moment of discharge, as it usually results from the accumulation of unresolved communication gaps throughout the hospital stay. Discharge may be viewed as a narrowing point in the care pathway: both the amount and the quality of information that successfully passes through must be carefully managed, so that what ultimately reaches the patient—and leaves with them—is sufficient, relevant, and meaningful.2 Many of these pieces of information must subsequently be translated into actions by the patient and therefore need to be practically applicable and enabling. During hospitalization, communication exchanges should be approached with a forward-looking perspective, as a sequence of interdependent steps. This allows progressive adjustment to the patient’s communicative abilities, which is essential for identifying and sharing priorities and for reaching discharge with a concise set of key messages and clear instructions on symptom management, medication use, risk factors, and strategies for their control (Figure 1). The phases of communication from the beginning of hospitalization to discharge. The sequence is determined by the progressive relevance of the objectives to be achieved, with a gradual narrowing of the focus on the patient and with a selection of information that takes into account the patient’s priorities and not only the disease. For each phase, the main objective and the operational sub-objectives are indicated; in addition, the communication skills that the physician must possess in order to achieve them are reported. Achieving the objectives of one phase is a pre-requisite for moving on to the subsequent phase and thus for arriving at good communication at discharge. Today, more than in the past, physician–patient communication can be challenging, and a stable, effective connection is not always achieved or maintained. Shorter hospital stays reduce the time available for dialogue, increasing the likelihood of information gaps and misunderstandings. These, in turn, may amplify organizational barriers to an effective discharge, such as the absence of standardized procedures and insufficient coordination among healthcare professionals. There are no specific categories of ‘critical’ patients; actually, there are recurrent situations which, if not adequately addressed from a communication standpoint, may weaken the physician–patient relationship and consequently affect the quality not only of discharge but of the entire care pathway (Table 1). Table 1The most frequent communication barriers: what to do to overcome them without compromising the relationship with the patient The most frequent communication barriers: what to do to overcome them without compromising the relationship with the patient Effective communication requires an appropriate setting. When a dedicated space is unavailable, the environment should be managed to minimize interference. If discharge communication occurs in a crowded corridor, the physician’s posture and positioning remain relevant: standing with the back to the wall and facing the patient helps convey availability and attention rather than haste. Eye contact should be established and maintained, particularly in contexts where multiple healthcare professionals are present and engaged in parallel activities. The internal structure of verbal messages is also important. Key information should be presented at the beginning of the sentence, reiterated at the end, and reinforced through consistent non-verbal cues, including tone of voice and gestures, to enhance clarity and retention. The ability to deliver bad news is a core communication competence. Clinicians must identify what constitutes bad news from the patient’s perspective and use an appropriate approach to avoid communication that appears abrupt, detached, or uncomfortable. Information becomes bad news when it negatively alters an individual’s expectations regarding present or future life conditions.3 For patients, the perceived loss of opportunities and the discrepancy between expectations and reality often weigh more than objective clinical severity in defining the information as distressing.4 There is no universal formula for communicating bad news, given the number of variables involved. However, specific communication strategies can increase effectiveness and reduce common errors, which are frequently associated with distraction, time pressure, and inadequate exploration of patient expectations (Table 2). Table 2Key points for communicating bad news Key points for communicating bad news Assessment of informational needs should take into account both age and gender. Young individuals without a prior history of disease may leave the hospital without fully understanding their diagnosis or the importance of preventive strategies, while frail, elderly adults may risk being discharged with therapeutic plans that are difficult to sustain, complex, or challenging to remember and implement.5 Women should receive information on gender-specific cardiovascular risk factors, which vary across different age groups, as well as on psychosocial stressors related to gender roles. The need for clarifications is often greater in women than in men. Young women frequently lack caregiver support and may be required to manage multiple roles simultaneously,6 whereas elderly women are often less autonomous. In both situations, specific lifestyle recommendations are necessary, and pharmacological treatment planning should consider the higher likelihood of sub-optimal adherence observed in women, which may require targeted motivational support. Consistency in communication among all healthcare professionals involved in the care pathway should be ensured. Nurses should be actively involved in discharge preparation, as their closer and more frequent contact with patients and family members may provide valuable insights, including an assessment of whether the patient and caregiver feel ready for discharge. Hospital discharge as a process: a systematic approach Discharge planning during hospitalization Effective hospital discharge management requires that discharge planning be initiated at the time of admission. Early assessment of the clinical complexity underlying hospitalization, together with evaluation of the patient’s overall condition and degree of frailty, allows the development of an individualized plan that supports appropriate length of stay and suitable post-discharge pathways. Discharge should therefore be regarded as a process that begins at admission and involves the patient and, when appropriate, the caregiver. When adequately informed about the clinical situation, patients and caregivers can actively contribute to defining the different management steps, up to the transition from hospital to home or to another healthcare or social-care facility. International guideline recommendations7 support the use of structured discharge approaches, as these are associated with reduced 1-year mortality. These documents outline key steps for discharge after an acute event, specifying objectives, responsible professionals, and operational tools.8,9 Conversely, when discharge is managed in a non-standardized manner and considered secondary to in-hospital treatment, the benefits achieved during the acute phase may be rapidly lost, with an increased risk of early hospital readmission. A proper discharge process requires an integrated, multidisciplinary team (MDT) approach. Physicians and nurses play a central role and are responsible for overseeing all phases, including the key transitions that connect the patient, caregivers, primary care physicians, and any intermediate services potentially involved after discharge, such as inpatient or outpatient cardiac rehabilitation (CR), cardiology clinics for secondary prevention, and services dedicated to continuity of care. Discharge planning is based on an appropriate assessment phase, which should be performed at admission and repeated during hospitalization as clinical conditions evolve. The definition of post-hospital care pathways should be completed before the planned discharge date. Only coordinated involvement of all stakeholders—sharing objectives, tools, implementation strategies, and roles—ensures an effective process (Table 3). Table 3Key points for a planned hospital discharge Key points for a planned hospital discharge Multidimensional assessment of patient’s needs and individualized discharge planning The epidemiological transition has led to a substantial increase in the number of elderly patients with chronic cardiovascular disease, frequently characterized by multi-morbidity and frailty. These conditions are associated with a higher risk of complications related both to the underlying disease and to diagnostic and therapeutic interventions—as well as increased mortality, rehospitalization, disability (defined as limitations in performing basic or instrumental activities of daily living), reduced quality of life, and greater healthcare resource utilization.10 Frailty is a multifactorial syndrome characterized by progressive biological decline, particularly affecting cognitive function, muscle strength, gait speed, endurance, asthenia, and unintentional weight loss, resulting in increased vulnerability to stressors.11 Although age is not included in formal definitions of frailty, advancing age is strongly associated with a higher likelihood of this condition. Consequently, cardiologists are frequently faced with hospitalized elderly patients who present multi-morbidity, disability, and frailty, representing a population that differs substantially from those enrolled in clinical trials. This scenario requires integrated and holistic approaches at discharge, shifting the focus from the single disease to the overall complexity of the individual. One possible response, both at the individual clinician level and within healthcare systems, is the adoption of multidimensional assessment (MDA) processes aimed at systematically defining the patient’s clinical and care profile. Multidimensional assessment can be defined as an inter-disciplinary diagnostic process that complements routine clinical evaluation, with the objective of quantifying medical, psychosocial, and functional problems. Its purpose is to develop a comprehensive plan for treatment, care, and short- and long-term follow-up, while also supporting safe and appropriate discharge planning.12 Multidimensional assessment enables an integrated and objective evaluation by using validated scales and tools exploring multiple health domains, including physical and functional status, psychological well-being, cognitive performance, and socio-economic factors (Table 4). Table 4Core tools for multidimensional geriatric assessmentDomainPrimary recommended toolsAlternative tools/notesFunctional statusADL (Katz) + IADL (Lawton & Brody)Barthel Index (preferred in rehabilitation)Cognitive functionMoCAMMSE + Clock Drawing Test; AMT (if patient cannot write)MoodCES-DGeriatric Depression Scale (15 or 30 items)SarcopeniaSARC-F + Handgrip StrengthIf positive → Bioimpedance analysisPhysical performance/fallsSPPB; Tinetti Scale400-m Walk Test; TUG; Gait Speed; Handgrip StrengthNutritional statusMNABioimpedance analysis; DEXAComorbiditiesCIRS-GCharlson Comorbidity IndexPolypharmacyNumber of MedicationsSTOPP/START CriteriaSocio-economic situationLiving arrangement; caregiver presence; social/recreational participation; housing conditions; financial resources—Quality of lifeEuroQol-5DSF-36FrailtyFrailty Index (Rockwood)Frailty Phenotype (Fried)ADL, activities of daily living; AMT, abbreviated mental test; CES-D, center for epidemiological studies depression scale; CIRS-G, cumulative illness rating scale for geriatrics; DEXA, dual-energy X-ray absorptiometry; IADL, instrumental activities of daily living; MMSE, mini mental state examination; MNA, mini nutritional assessment; SARC-FSPPB, strength, assistance in walking, rise from a chair, climb stairs, falls – falls, short physical performance battery; SF-36, short form 36 health survey; START, screening tool to alert doctors to right treatment; STOPP, screening tool of older persons' prescription; TUG, timed up and go test. Core tools for multidimensional geriatric assessment ADL, activities of daily living; AMT, abbreviated mental test; CES-D, center for epidemiological studies depression scale; CIRS-G, cumulative illness rating scale for geriatrics; DEXA, dual-energy X-ray absorptiometry; IADL, instrumental activities of daily living; MMSE, mini mental state examination; MNA, mini nutritional assessment; SARC-FSPPB, strength, assistance in walking, rise from a chair, climb stairs, falls – falls, short physical performance battery; SF-36, short form 36 health survey; START, screening tool to alert doctors to right treatment; STOPP, screening tool of older persons' prescription; TUG, timed up and go test. Implementation of MDA requires a dedicated team, often referred to as an assessment unit, whose composition may vary. It typically includes a physician—preferably with geriatric expertise—a nurse, an occupational therapist, a physiotherapist, and a social worker.13 However, not all hospital settings have the staffing and resources needed to fully implement such an organizational model. For this reason, cardiologists should be familiar with at least the essential tools required for basic multidimensional evaluation. MDA allows the following: evaluation of the risk and degree of loss of autonomy, to determine the need for ongoing assistance; evaluation of the risk and degree of loss of autonomy, to determine the need for ongoing assistance; formulation of an individualized care plan (ICP), based on the need for rehabilitation, monitoring and/or nursing support, assistive devices for daily living, presence of architectural barriers, availability of informal support, and social contacts. While clinical care pathways aim to standardize care for defined patient categories, the ICP is designed to personalize the care pathway for the individual patient; and formulation of an individualized care plan (ICP), based on the need for rehabilitation, monitoring and/or nursing support, assistive devices for daily living, presence of architectural barriers, availability of informal support, and social contacts. While clinical care pathways aim to standardize care for defined patient categories, the ICP is designed to personalize the care pathway for the individual patient; and identification of the most appropriate setting for care delivery, such as long-term care facilities, community health centres, or integrated home care services.14 identification of the most appropriate setting for care delivery, such as long-term care facilities, community health centres, or integrated home care services.14 Several studies have shown that MDA is associated with improved survival, better functional and psychological outcomes, and reduced rehospitalization. Recent national legislation has formally recognized the importance of MDA as a tool to facilitate access to services for elderly and frail individuals, and its role has been further emphasized within community-based access models. The multidisciplinary and inter-professional team in discharge planning Discharge planning is one of the most common activities in hospital settings, where the inter-professional team plays a central role in supporting the transition to home or to another care facility.15 The proportion of patients readmitted to hospital within the first year after an episode of heart failure has been estimated at ∼60.9%.16 For this reason, the development of a structured and individualized discharge plan aimed at addressing both healthcare and social needs is strongly recommended to reduce avoidable readmissions. The Institute of Medicine identifies planned, timely, efficient, and safe hospital discharge as an indicator of high-quality care.17 Length of hospital stay is also considered a key performance indicator and a target of healthcare planning. However, hospitals frequently encounter difficulties in consistently meeting discharge targets and organizational benchmarks.18 Unstructured collaboration and communication among members of multidisciplinary and multi-professional teams are recognized sources of information duplication, role overlap, and fragmentation of responsibilities, potentially leading to inter-professional conflict.19 Multidisciplinary teams operate across both hospital and community settings; nevertheless, in highly fragmented organizational contexts, communication at discharge may be ineffective, creating barriers to continuity of care and compromising appropriate handover to other professionals.20 Effective discharge planning has positive implications not only for patients and their families or caregivers but also for healthcare organizations. It is associated with reduced hospital readmission rates, shorter hospital stays, increased patient satisfaction, and improved overall management of hospitalization.21 To ensure effective discharge planning within a MDT, coordination among professionals must be structured, collaboration among team members must be active, and each professional’s roles and responsibilities must be clearly defined and understood by the entire team (Figure 2). Management of the discharge process by the multidisciplinary assessment team. Among the actors involved in the discharge process, the patient must be considered an active participant in care decisions.22 Evidence indicates that active patient engagement during hospitalization and at discharge improves understanding of the clinical condition and reduces hospital readmissions.23 Across acute, rehabilitative, and community or home-care settings, effective inter-professional care models are required to support patients and families. These models should include strategies to strengthen coordination and collaboration within and between MDTs. Several studies show that MDT interventions improve clinical outcomes and patient satisfaction; however, evidence specifically addressing the effectiveness of teamwork during the discharge process remains limited.24 Useful information for the nurse Hospital discharge is a key stage in the care pathway, as it represents the transition from a monitored clinical setting to an environment in which the patient is required to manage treatment and follow-up independently or with caregiver support. A structured discharge process is therefore necessary to ensure continuity of care and to limit complications and unplanned readmissions. In this context, nurses have a central role because of their continuous contact with patients and families.1,25 During the initial assessment, nurses evaluate clinical stability, the patient’s ability to self-manage, and existing care needs.26 This phase includes a review of medication therapy and an assessment of available social and family resources, enabling early identification of support requirements.27 Discharge planning is then carried out in collaboration with the MDT—such as cardiologists, physiotherapists, nutrition specialists, or other professionals according to clinical needs—allowing the definition of realistic goals and the organization of follow-up visits or home care services. Education of patients and caregivers is a core component of the process. Nurses provide clear, tailored information on therapies, diet, physical activity, and recognizing warning signs of clinical instability. Verification of understanding is essential and can be supported through teach-back strategies, written materials, or practical demonstrations.1,26 Programmes that combine discharge planning with post-discharge support are associated with better outcomes.28 Nurses also facilitate access to community nursing services, specialist consultations, and social or volunteer networks, helping to maintain support after discharge.28 The final step involves planning appropriate post-discharge follow-up. When required, nurses may arrange early telephone contacts or short-term visits to assess adherence and clinical stability and to detect early signs of deterioration.29 These measures contribute to reducing rehospitalizations and improving patients’ sense of security. Overall, hospital discharge requires coordinated management in which nurses, through organizational and relational competencies, support a safe transition and promote the achievement of health objectives and patient well-being.30 Useful Information for the dietitian Dietary habits are among the major determinants of health and of the global burden of disease, and most countries worldwide face one or more forms of malnutrition, whether due to deficiency or excess. Unhealthy dietary patterns: influence major cardiovascular risk factors, including dyslipidaemia, hypertension, body weight, and diabetes, thereby contributing to overall cardiovascular risk31 and influence major cardiovascular risk factors, including dyslipidaemia, hypertension, body weight, and diabetes, thereby contributing to overall cardiovascular risk31 and account for approximately half of deaths and disabilities related to cardiovascular diseases and are associated with a substantial economic impact in the European Union, with estimated costs of €102 billion annually.32 account for approximately half of deaths and disabilities related to cardiovascular diseases and are associated with a substantial economic impact in the European Union, with estimated costs of €102 billion annually.32 Healthy nutrition represents the most relevant behavioural factor in the prevention of premature cardiovascular mortality and disability, exceeding the impact of smoking cessation and adequate physical activity.33 In 2022, Dai et al.34 reported that more than two-thirds of cardiovascular deaths worldwide could be prevented through healthy dietary patterns. In this context, adopting appropriate dietary choices as an integral component of cardiovascular care is essential and consistent with current guideline recommendations. In particular, the recent European Society of Cardiology Guidelines advocate a Mediterranean-style dietary pattern to reduce cardiovascular risk in all individuals (Table 5).31 Table 5Key dietary components and nutritional recommendations in cardiovascular preventionKey componentMain characteristicsClinical considerationsMediterranean dietPrimarily based on extra-virgin olive oil, whole grains, legumes, fresh and dried fruit, vegetables; moderate amounts of fish, dairy products, and meatDietary pattern associated with reduced cardiovascular mortality. Food portions should be individualized with a dietitian according to patient clinical status and food availability.Whole grainsOne or two servings per meal (bread, pasta, rice, or other cereals), preferably whole grainPromote high-fibre foods due to beneficial effects on glucose and lipid metabolism.Fruit and vegetablesAt least five servings per dayVariety in colour and texture provides a broad spectrum of antioxidants and protective bioactive compounds.Extra-virgin olive oilMain source of dietary fat due to high nutritional qualityLong-term adherence to an extra-virgin olive oil-rich Mediterranean diet is associated with slower progression of atherosclerosis. Suitable for cooking and seasoning due to stability at high temperatures.Saturated fatty acids<10% of total energy intakeReduce saturated fats by replacing them with mono- and polyunsaturated fats; encourage fish consumption at least twice weekly. Prefer lean meat and cheeses with ≤25% fat content.Trans fatty acids<1% of total energy intakeIntake should be minimized, preferably avoiding processed foods.AlcoholMaximum safety threshold ≈100 g ethanol per weekAlcohol consumption is not necessary. The American Heart Association does not recommend initiating alcohol intake for cardiovascular benefit.Salt (sodium chloride)≤5 g/day; <1.5 g/day in selected conditionsPatients should be educated on the health impact of excessive salt intake.Water/fluids1.5–2.5 L/day under normal conditions; <1.5 L in selected situationsIn heart failure patients, fluid intake is generally guided by thirst. Requirements may increase in hot/humid environments or with excessive sweating.Energy intakeAdequate caloric intake to achieve and maintain healthy body weightEducate patients on the relationship between energy intake, body weight, and waist circumference. In patients with reduced intake or dysphagia, increase meal energy density, modify food texture, and consider oral nutritional supplements or enteral nutrition if needed. Higher protein intake may be considered in older adults to preserve muscle mass. Provide educational materials. Key dietary components and nutritional recommendations in cardiovascular prevention The World Health Organization recognizes nutritional literacy as a central element in the prevention and control of non-communicable diseases.35 The acquisition of basic nutritional knowledge is fundamental for empowering patients and enabling informed dietary decisions.33,36-41 Moreover, multi-morbidity—with or without age-related frailty—is frequently associated with nutritional issues that may coexist with metabolic disturbances. This may necessitate the use of energy-dense foods, texture-modified diets and fluids, or, in selected cases, artificial nutrition. Early identification of nutritional risk is therefore crucial, and clinical guidelines recommend routine screening in elderly adults.36 Treatment goals are established based on the nutritional diagnosis,37 a process that identifies and describes nutrition-related problems that can be resolved or improved through dietetic intervention. Close collaboration among members of the cardiology care team is essential to achieve nutritional targets and optimize patient outcomes (Table 2). Physiotherapy contributions to discharge planning Resumption of physical activity after hospital discharge in cardiology patients must be individualized according to clinical status, in-hospital course, length of stay, and additional factors such as comorbidities, severity of the acute event, and age.42 Careful evaluation of functional status is required, as patients may range from physically fit individuals to those with severe functional limitations. This assessment is essential for defining a safe and effective rehabilitation pathway. The main objectives of post-discharge physical activity include improving cardiac function and quality of life, preventing recurrence, and promoting patient autonomy. Appropriate determination of exercise intensity is a key element in cardiovascular rehabilitation, directly affecting both effectiveness and safety.43 During the first weeks after discharge, high-intensity physical activity should be avoided. Exercise intensity can be guided by target heart rate (typically 50–85% of age-predicted maximum heart rate), perceived exertion on the Borg scale, and the Talk Test, which indicates the patient should be able to speak without difficulty during activity. Exercise modalities should be adapted to the patient profile: sedentary individuals may begin with short walks and stretching; patients with better baseline fitness may perform light aerobic exercise; and elderly individuals should perform exercises to improve balance and muscle strength. Continuous monitoring of the cardiovascular response during physical activity is necessary, and symptoms should be reported promptly. Guidelines recommend low-impact aerobic activities that enhance cardiovascular endurance, such as cycling on a low-resistance stationary bicycle with a gradual progression to higher workloads or outdoor cycling. Resistance training with light weights and low loads is also recommended, favouring sessions with more repetitions. Circuit training, combining resistance and aerobic components, may improve overall physical condition. Functional activities such as brisk walking and stair climbing should be integrated into recovery programmes. When patients are referred to structured CR programmes, individualized pathways including supervised exercise, psychological support, and nutritional counselling are associated with reduced complication risk and improved functional capacity. At discharge, the cardiologist should provide clear guidance on gradually increasing physical activity. Patients should be encouraged to walk, even at a slow pace, both indoors and outdoors, use stairs when possible, and participate in group activities that promote social engagement, such as low-intensity exercise classes or walking groups, while appropriately monitoring exercise intensity. The long-term goal is to achieve 30–60 min of moderate-intensity aerobic physical activity on at least 5 days per week.44 Even lower levels of activity provide clinically relevant benefits, including improved mobility, autonomy, mood, and social participation, particularly in elderly adults (Table 6).45 Table 6Type, effects, and recommendations for daily physical activitiesPhysical activityBenefitsDetails and recommendationsWalking (slow or moderate pace)Improves mobility and independence, promotes social interactionWalking daily, even at low intensity, helps maintain muscle activity and improves circulation.Climbing stairsIncreases endurance, supports cardiac function, strengthens muscle toneStart gradually to avoid excessive exertion. Stair climbing is an excellent cardiovascular exercise that requires no equipment.Participating in walking groupsSocial engagement, mutual support, increased motivationGroup activities encourage socialization and make exercise more enjoyable and sustainable.Light gymnasticsImproves flexibility and strength, reduces stressLow-intensity exercises help enhance overall well-being and reduce muscular tension.Goal (30–60 min of moderate aerobic activity)Improves prognosis in ischaemic heart disease, supports heart healthRegular aerobic activity reduces the risk of cardiac complications and improves mood. Exercise intensity should always be monitored. Type, effects, and recommendations for daily physical activities Management of pharmacological and non-pharmacological therapy Lifestyle recommendations Lifestyle exerts a substantial influence on prognosis after hospitalization for an acute event. Hence the importance of intervening on all those lifestyle habits that, if modified, allow improvement in the outcome after discharge. Smoking cessation is a major priority among lifestyle interventions. Patients should be informed about the risks associated with tobacco use and strongly encouraged to achieve permanent abstinence. Strategies to support smoking cessation include structured counselling, psychological support, and, when indicated, pharmacological therapy. Other important components of lifestyle management after hospitalization include physical activity and nutrition, which are discussed in dedicated sections of this document. Recommendations to improve treatment adherence Adherence to prescribed therapies is a key determinant of clinical outcomes; therefore, all feasible measures to support medication adherence should be implemented.46 One effective strategy is to initiate treatment during hospitalization or within a structured CR programme, where patients can receive clear explanations about the purpose of each therapy, possible adverse effects, and practical guidance on their management. The use of fixed-dose combination therapies has been shown to enhance adherence, contribute to improved prognosis,47 and offer advantages in terms of cost-effectiveness.48 Medication reconciliation At discharge, it is essential to implement medication reconciliation by reviewing the patient's previous therapy and, for each drug, providing clear instructions on continuation, possible dosage adjustments, or discontinuation. Careful attention to this process helps reduce errors due to incomplete information. Medication reconciliation may also represent an opportunity for deprescribing drugs that no longer provide benefit in a clinical context modified after the acute event, with a favourable impact on treatment adherence as well.46 Release of therapeutic plan cards The prescription and reimbursement of several medications require the compilation of therapeutic plan cards. In authorized centres, physicians at the time of discharge are required to complete therapeutic plans and/or monitoring forms for all medications under their responsibility (Table 7), in order to overcome one of the barriers to treatment continuation and adherence. Table 7Cardiological drugs for which the completion of therapeutic plans or monitoring forms is required for reimbursement by the National Health ServiceTherapeutic classDrugsIndicationsDOACsApixaban, dabigatran, edoxaban, rivaroxabanAtrial fibrillation; Pulmonary embolism; Prevention/treatment of deep vein thrombosis; aperipheral artery diseaseP2Y12 receptor inhibitors (anti-platelets)Prasugrel, ticagrelorAcute coronary syndromeATP-citrate lyase inhibitor (lipid-lowering)Bempedoic acidHypercholesterolaemia; primary and secondary cardiovascular preventionPCSK9 inhibitor monoclonal antibodiesAlirocumab, evolocumabFamilial hypercholesterolaemia; secondary cardiovascular preventionPCSK9 siRNA therapyInclisiranFamilial hypercholesterolaemia; secondary cardiovascular preventionARNISacubitril/valsartanHeart failure with reduced ejection fractionSoluble guanylate cyclase stimulatorVericiguatHeart failure with reduced ejection fractionAnti-anginal agentRanolazineRefractory anginaSGLT2 inhibitorsDapagliflozin, empagliflozinHeart failure; Type 2 diabetes mellitusGLP-1 receptor agonistSemaglutideType 2 diabetes mellitusARNI, angiotensin receptor–neprilysin inhibitor; DOACs: direct oral anticoagulants; GLP-1 RA, glucagon-like peptide-1 receptor agonists; PCSK9, pro-protein convertase subtilisin/kexin type 9; SGLT2-i, sodium–glucose co-transporter 2-inhibitor. Cardiological drugs for which the completion of therapeutic plans or monitoring forms is required for reimbursement by the National Health Service ARNI, angiotensin receptor–neprilysin inhibitor; DOACs: direct oral anticoagulants; GLP-1 RA, glucagon-like peptide-1 receptor agonists; PCSK9, pro-protein convertase subtilisin/kexin type 9; SGLT2-i, sodium–glucose co-transporter 2-inhibitor. Medication supply at discharge At discharge, in addition to detailed therapeutic prescriptions specifying administration route, dosage, and timing, it is advisable to provide the patient with all prescribed medications in quantities sufficient to cover the period between hospital discharge, reassessment by the general practitioner (GP) with issuance of prescriptions covered by the National Health Service (when applicable), and drug procurement from community pharmacies. This practice aims to ensure continuity of therapy and is particularly important when a patient is prescribed new medications. Post-acute pathway and secondary prevention Cardiac rehabilitation pathway At discharge after an acute cardiovascular event, direct referral to a CR programme represents the most cost-effective strategy to achieve multiple care objectives, including further clinical stabilization, reduction of disability related to the underlying heart disease, favourable lifestyle modification (smoking cessation, diet, and physical activity), and the provision of appropriate psychosocial support.42 For a detailed description of the components and professional figures involved in the rehabilitation pathway, refer to the dedicated documents.49 Virtually, every major cardiovascular event is appropriate for referral to CR; however, in the current national context, patients with coronary disease or heart failure represent the main target population, not only due to their epidemiological relevance but also because of the stronger evidence supporting the effectiveness of rehabilitation interventions, particularly in terms of event reduction and lowering of residual risk.50,51 Cardiac rehabilitation programmes are delivered after discharge in either inpatient or outpatient settings, depending on patient characteristics and local availability. Inpatient rehabilitation is provided in structured hospital units, recently surveyed as 116 nationwide, with a total of 2075 beds,52 and is mostly classified under the ministerial code 56, which identifies intensive rehabilitation. Inpatient facilities may be located within the same hospital as the acute cardiology ward, in separate facilities, or within different healthcare institutions. Inpatient CR activities have recently undergone regulatory revision (Ministerial Decree of 5 August 2021, ‘Criteria for appropriateness of access to hospital rehabilitation admissions,’ and further updates), which established appropriateness criteria based on combined evaluation of the hospital discharge report from both the acute and rehabilitation units, timing of patient transfer, and levels of intervention complexity. Outpatient pathways may be delivered in day-hospital, day-service, or complex outpatient settings, provided that an adequate quantitative and qualitative level of rehabilitation intervention is ensured to achieve the predefined clinical and prognostic goals. The system scenario described above, together with the well-known shortage of rehabilitation facilities relative to potential demand, significantly affects the referral process to CR at discharge. The current CR referral rate reported by Agenzia Nazionale per i Servizi Sanitari Regionali, below 10% after acute coronary syndrome at a national level,53 highlights a marked misalignment with recommendations from major international guidelines, which almost unanimously assign a Class I, Level A recommendation to CR interventions. This situation—given its potential implications in terms of physicians’ professional responsibility—unmet obligations of care by hospital institutions, and, above all, population health loss cannot be simplistically accepted as being due to inevitable reasons. Consequently, the discharge process from an acute hospital ward should systematically include the following actions by the responsible physician: Consideration of a subsequent rehabilitation phase with appropriate individualized goals. Consideration of a subsequent rehabilitation phase with appropriate individualized goals. Identification of clinical conditions in which transfer to rehabilitation is not only appropriate but also a priority, differentiating between inpatient and outpatient settings (Table 8).54-57 Identification of clinical conditions in which transfer to rehabilitation is not only appropriate but also a priority, differentiating between inpatient and outpatient settings (Table 8).54-57 In cases where referral to the CR is not possible, the condition preventing referral must be formally documented in the medical record and the ‘best possible alternative’ must be organized to structure the subsequent care pathway (Figure 3) with specific adjustments for geriatric patients available in dedicated documents.54 In cases where referral to the CR is not possible, the condition preventing referral must be formally documented in the medical record and the ‘best possible alternative’ must be organized to structure the subsequent care pathway (Figure 3) with specific adjustments for geriatric patients available in dedicated documents.54 Operational flow chart for the management of ‘referral’ and ‘no referral’ to cardiac rehabilitation at discharge from an acute care ward. Criteria for taking charge of the patient are as follows: availability of a territorially compatible cardiac rehabilitation centre, availability of an appropriate care setting (inpatient or non-inpatient), time to taking charge, and consistency between the acute hospital discharge summary and the rehabilitative hospital discharge summary, ensured in accordance with the 2021 Ministerial Decree. Best possible alternative are as follows: oriented towards the main objectives of maintaining clinical stability, reducing residual risk, reducing disability, lifestyle modification, and psychosocial support (e.g. structured outpatient follow-up, a shared care pathway with the GP, integrated rehabilitative home care, activation of the family and community nurse, referral to health gyms with a structured physical exercise programme, referral to smoking cessation centres, and counselling services with educational and psychological activities). In case there is a need to continue hospitalization in facilities with a lower intensity of care, appropriate instructions should be drafted in the discharge letter. Table 8Priority criteria for referral to cardiac rehabilitation after discharge from an acute care wardQualifying diagnosis for referral to cardiac rehabilitationPriority criteriaSequelae of acute coronary syndrome and/or percutaneous coronary interventionPriority referral to inpatient rehabilitation in the presence of high clinical risk of heart failure or adverse left ventricular remodelling:myocardial infarction (MI) with heart failure (even mild) in the acute phase;LVEF <40%;LVEF 40–45% with at least one predictor of remodelling (mitral regurgitation >1+, restrictive diastolic filling, high wall motion score index, non-dilated ventricle); andMI with prolonged acute hospitalization, complications, or comorbidities.Priority referral to a rehabilitation cycle, preferably outpatient, in patients with high thrombotic (residual ischaemic) risk:High residual cardiovascular risk, diabetes mellitus, renal failure, peripheral artery disease, history of angina or prior MI, multi-vessel disease or complex lesions, incomplete revascularization, failed revascularization/reperfusion, prior restenosis or stent thrombosis.Heart failure Priority referral to inpatient rehabilitation in the presence of a medium–high risk profile:NYHA class III–IV at discharge;electrical instability;need for optimization of pharmacological therapy;clinical instability and/or after prolonged or complicated hospitalization; andUnder evaluation for heart transplantation or VAD.Also priority referral to inpatient rehabilitation for:possible candidates for device implantation after recent ACS with pump dysfunction, to assess potential recovery of LV function after revascularization and/or guideline-directed medical therapy andpatients with recent device implantation and clinical/electrical instability or surgical complications.Chronic coronary syndromePriority referral to inpatient rehabilitation in patients with severe disability related to heart disease (low-threshold angina), high risk of heart failure, high thrombotic risk, or high arrhythmic risk with logistical barriers to outpatient treatment.Sequelae of coronary, valvular, or major vascular cardiac surgeryPriority referral to inpatient rehabilitation in the presence of:surgery following a coronary event;advanced age;high risk of heart failure; andprolonged or complicated acute hospital stay.Sequelae of percutaneous valve procedures (TAVI, MitraClip, TriClip) and elective cardiac device implantation (PM, ICD, CRT)Priority referral to inpatient rehabilitation in the presence of:procedure following a coronary event;advanced age;high risk of heart failure;prolonged or complicated acute stay; andneed for device reassessment during physical training.Pulmonary embolismPriority referral to rehabilitation (inpatient or outpatient) in the presence of haemodynamic instability during the acute event and/or thrombolysis/thrombectomy procedures.Lower limb PADPriority referral to inpatient rehabilitation in patients:after surgical or percutaneous revascularization, at high risk of MACE and MALE;with trophic lesions or complex wounds;with haemodynamic or cardiac rhythm instability.In patients with PAD and intermittent claudication, an outpatient rehabilitation programme is considered a priority for supervised exercise training aimed at restoring walking autonomy, achieving therapeutic targets rapidly, and promoting healthy lifestyle habits.ACS, acute coronary syndrome; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter-defibrillator; LV, left ventricle; LVEF, left ventricular ejection fraction; MACE, major adverse cardiovascular event; MALE, major adverse limb event; NYHA, New York Heart Association; PAD, peripheral arterial disease; PM, pacemaker; TAVI, transcatheter aortic valve implantation; VAD, ventricular assist device. Adapted from.50-52 Priority criteria for referral to cardiac rehabilitation after discharge from an acute care ward myocardial infarction (MI) with heart failure (even mild) in the acute phase; myocardial infarction (MI) with heart failure (even mild) in the acute phase; LVEF <40%; LVEF <40%; LVEF 40–45% with at least one predictor of remodelling (mitral regurgitation >1+, restrictive diastolic filling, high wall motion score index, non-dilated ventricle); and LVEF 40–45% with at least one predictor of remodelling (mitral regurgitation >1+, restrictive diastolic filling, high wall motion score index, non-dilated ventricle); and MI with prolonged acute hospitalization, complications, or comorbidities. MI with prolonged acute hospitalization, complications, or comorbidities. High residual cardiovascular risk, diabetes mellitus, renal failure, peripheral artery disease, history of angina or prior MI, multi-vessel disease or complex lesions, incomplete revascularization, failed revascularization/reperfusion, prior restenosis or stent thrombosis. High residual cardiovascular risk, diabetes mellitus, renal failure, peripheral artery disease, history of angina or prior MI, multi-vessel disease or complex lesions, incomplete revascularization, failed revascularization/reperfusion, prior restenosis or stent thrombosis. Priority referral to inpatient rehabilitation in the presence of a medium–high risk profile: Priority referral to inpatient rehabilitation in the presence of a medium–high risk profile: NYHA class III–IV at discharge; NYHA class III–IV at discharge; electrical instability; electrical instability; need for optimization of pharmacological therapy; need for optimization of pharmacological therapy; clinical instability and/or after prolonged or complicated hospitalization; and clinical instability and/or after prolonged or complicated hospitalization; and Under evaluation for heart transplantation or VAD. Under evaluation for heart transplantation or VAD. possible candidates for device implantation after recent ACS with pump dysfunction, to assess potential recovery of LV function after revascularization and/or guideline-directed medical therapy and possible candidates for device implantation after recent ACS with pump dysfunction, to assess potential recovery of LV function after revascularization and/or guideline-directed medical therapy and patients with recent device implantation and clinical/electrical instability or surgical complications. patients with recent device implantation and clinical/electrical instability or surgical complications. surgery following a coronary event; surgery following a coronary event; advanced age; advanced age; high risk of heart failure; and high risk of heart failure; and prolonged or complicated acute hospital stay. prolonged or complicated acute hospital stay. procedure following a coronary event; procedure following a coronary event; advanced age; advanced age; high risk of heart failure; high risk of heart failure; prolonged or complicated acute stay; and prolonged or complicated acute stay; and need for device reassessment during physical training. need for device reassessment during physical training. after surgical or percutaneous revascularization, at high risk of MACE and MALE; after surgical or percutaneous revascularization, at high risk of MACE and MALE; with trophic lesions or complex wounds; with trophic lesions or complex wounds; with haemodynamic or cardiac rhythm instability. with haemodynamic or cardiac rhythm instability. ACS, acute coronary syndrome; CRT, cardiac resynchronization therapy; ICD, implantable cardioverter-defibrillator; LV, left ventricle; LVEF, left ventricular ejection fraction; MACE, major adverse cardiovascular event; MALE, major adverse limb event; NYHA, New York Heart Association; PAD, peripheral arterial disease; PM, pacemaker; TAVI, transcatheter aortic valve implantation; VAD, ventricular assist device. Adapted from.50-52 Post-discharge outpatient pathway The post-discharge outpatient pathway for cardiac patients following an acute event plays a fundamental role in continuity of care, enabling ongoing clinical monitoring, optimization of pharmacological therapy, and promotion of appropriate secondary prevention measures. The care pathway must be timely and structured to significantly contribute to the reduction of rehospitalizations, with benefits in terms of clinical outcomes and quality of life (Table 9). Table 9Outpatient pathway of the patient discharged from hospital after an acute eventPatient characteristicsCare pathwaysResponsible professionals1. Patients with a recent cardiovascular event (acute coronary syndrome, coronary revascularization, cardiac surgery, acute heart failure).2. Indication for cardiology follow-up.3. Enrolment in a cardiovascular rehabilitation programme.4. Possible presence of social or care needs.Outpatient cardiology follow-up (ideally within 7–14 days and in any case within 30 days). Subsequent visits at 3, 6, and 12 months.Nurse-led care management: multidimensional assessment of healthcare and social needs, educational intervention, monitoring during therapy titration, evaluation of adherence to shared care plans with the patient and family, and assessment of support needs for patients and caregivers.Specialist teleconsultation (diabetology, nephrology, pulmonology, etc.), when indicated.Data entry into the patient electronic record (PER). When appropriate, PER teleconsultation for activation of community care pathways.At each medical or nursing visit, a clinical report is issued for the GP.Ongoing community-based specialist follow-up, with timing and modalities individualized according to patient complexity.Early reassessment requested by the GP through specialist teleconsultation within the continuity-of-care pathway.CardiologistOther specialistsNursesGPPER and community healthcare servicesGP, general practitioner. Outpatient pathway of the patient discharged from hospital after an acute event GP, general practitioner. The hospital discharge phase marks the start of this pathway. The patient is provided with a detailed discharge report that specifies the date and modalities of the first outpatient reassessment, ideally scheduled within 7–14 days after hospital discharge (and in any case within 30 days). This timing is crucial for the early identification of possible signs of clinical instability and for verifying and implementing secondary prevention programmes, which include the following: optimization of pharmacological therapy (beta-blockers, Renin-Angiotensin System inhibitors, diuretics, anticoagulants, lipid-lowering agents, antiplatelet drugs, etc.) and verification of treatment adherence; optimization of pharmacological therapy (beta-blockers, Renin-Angiotensin System inhibitors, diuretics, anticoagulants, lipid-lowering agents, antiplatelet drugs, etc.) and verification of treatment adherence; adoption of healthy lifestyles (smoking cessation, regular physical activity, healthy diet or according to specific indications); adoption of healthy lifestyles (smoking cessation, regular physical activity, healthy diet or according to specific indications); psychological support and health education, aimed at improving adherence to therapy and disease awareness; and psychological support and health education, aimed at improving adherence to therapy and disease awareness; and possible referral to structured CR programmes. possible referral to structured CR programmes. Within the individualized follow-up programme, the frequency of subsequent visits—typically at 3–6 months and 12 months after the acute event—is modulated according to the individual risk and the underlying disease (myocardial infarction, heart failure, valvular disease, comorbidities, etc.). Thereafter, once the patient is stabilized and therapy optimized, visits may be spaced further apart, becoming annual and subsequently biennial. In this context, the outpatient cardiologist (whether hospital-based or working in community care facilities) serves as the specialist reference point, managing drug titration, scheduling follow-up investigations [echocardiography, exercise testing, and Holter electrocardiogram (ECG) monitoring], and indicating invasive or rehabilitation procedures when appropriate. A fundamental pre-requisite for community cardiology is the presence of an organizational structure (structural or functional, included within accredited private facilities) based on integrated specialist teams, ideally multidisciplinary (including diabetologists, nephrologists, pulmonologists, etc.), multi-professional, and equipped with the necessary diagnostic tools for at least first-level non-invasive patient assessment.59 Within this organization, the nursing outpatient clinic represents a crucial node for close clinical monitoring, MDA, and delivery of personalized health education interventions aimed at self-care and self-monitoring.26 The GP collaborates with the cardiologist to monitor the patient’s clinical course and manage associated conditions. Finally, protected hospital discharge represents an opportunity to promote multidisciplinary and multi-professional integration processes and tools, as well as territorial organizational-care models, in order to harmonize healthcare and social-care responses to the person’s health needs along the hospital–community continuity of care axis. Integration should be implemented at the level of the territorial operations centre, where available, which performs a coordinating function in patient care management and in linking services and professionals involved across different care settings.59 Telemedicine pathway Heart failure represents a clinical condition in which telemedicine has particularly relevant and paradigmatic applications, given the complexity of its management and the high burden of hospital utilization. The challenges associated with heart failure are well recognized and relate to the large number of affected patients and the high rate of hospital admissions. Although the literature consistently shows that structured post-discharge follow-up after hospitalization for heart failure is essential to reduce mortality and rehospitalization, only a limited proportion of patients are enrolled in dedicated outpatient follow-up programmes at discharge. The 2023 ESC Heart Failure Guidelines recommend the use of four foundational pharmacological classes—angiotensin receptor–neprilysin inhibitors (ARNI), beta-blockers, mineralocorticoid receptor antagonists, and sodium–glucose co-transporter 2 (SGLT2) inhibitors—which have been shown to reduce mortality and heart failure hospitalizations by ∼20%.60 The benefit of these therapies depends not only on initiation but also on early implementation and achievement of target dosages. The STRONG-HF trial demonstrated that an intensive post-discharge follow-up programme led by physicians and nurses significantly reduced mortality and rehospitalization at 180 days; however, such intensive models are difficult to implement in routine clinical practice.60 The post-discharge period (transitional care) following an acute event or heart failure exacerbation is associated with a high risk of mortality and rehospitalization.61 International guidelines, including ESC recommendations, support integrated home-based care pathways aimed at improving patient self-management, enhancing treatment adherence, enabling early detection of clinical instability, and reducing rehospitalizations (Figure 4).60 Management of a clinical pathway dedicated to telemedicine. GP, general practitioner; BP, blood pressure. Telemedicine services provide a potential solution by enabling patient follow-up within an integrated, multi-professional care pathway. Tele-assistance and tele-monitoring have demonstrated benefit in this setting, with meta-analyses reporting reductions in mortality and rehospitalization.62 Given the recognized role of CR as a key component of optimal heart failure management, tele-rehabilitation also represents an important strategy, both as an alternative setting to increase referral rates and as an option for long-term maintenance programmes (Figure 4).63 Risk-stratified tele-monitoring strategies may further support multidisciplinary management, reduce the need for in-person outpatient visits, and facilitate optimization and titration of guideline-directed medical therapy. Shared cloud-based data platforms can enhance communication among healthcare providers. Remote monitoring of clinical parameters (heart rate, blood pressure, body weight), instrumental data (oxygen saturation, ECG), and laboratory values (sodium, potassium, urinary albumin-to-creatinine ratio, creatinine, N-terminal pro-brain natriuretic peptide, and complete blood count) allows early identification of clinical deterioration and supports therapy adjustment. Criteria for patient selection are reported in Table 10; requirements for healthcare facilities and for patients or caregivers are detailed in Tables 11 and 12. Care pathways across different care settings and according to monitoring modality are described in Tables 13 and 14. Table 10Selection of the patients Tele-assistance and tele-monitoring eligibility Patients with implantable devices without heart failurePatients with chronic heart failure:Without implantable devicesWith implantable devicesGUCH patientsPatients with chronic artery disease at higher risk Tele-rehabilitation After cardiac surgeryIn chronic heart failureIn chronic artery disease at higher riskAfter recent interventional procedures (PCI and TAVI) GUCH, grown-up congenital heart disease; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation. Selection of the patients Patients with implantable devices without heart failure Patients with implantable devices without heart failure Patients with chronic heart failure:Without implantable devicesWith implantable devices Patients with chronic heart failure: Without implantable devices Without implantable devices With implantable devices With implantable devices GUCH patients GUCH patients Patients with chronic artery disease at higher risk Patients with chronic artery disease at higher risk After cardiac surgery After cardiac surgery In chronic heart failure In chronic heart failure In chronic artery disease at higher risk In chronic artery disease at higher risk After recent interventional procedures (PCI and TAVI) After recent interventional procedures (PCI and TAVI) GUCH, grown-up congenital heart disease; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation. Table 11Requirements for the hospital facility Use of institutional electronic systems for prescribing, booking, admission, and reportingElectronic agendas for specific servicesUse of institutional reporting systems and digital signaturePlatform for receiving sensor-derived signalsFull information disclosure and consent collectionTechnical verification and prior staff trainingPrior availability of patient documentationVideo call with recording integrated into the clinical recordClinical report available online Requirements for the hospital facility Use of institutional electronic systems for prescribing, booking, admission, and reporting Use of institutional electronic systems for prescribing, booking, admission, and reporting Electronic agendas for specific services Electronic agendas for specific services Use of institutional reporting systems and digital signature Use of institutional reporting systems and digital signature Platform for receiving sensor-derived signals Platform for receiving sensor-derived signals Full information disclosure and consent collection Full information disclosure and consent collection Technical verification and prior staff training Technical verification and prior staff training Prior availability of patient documentation Prior availability of patient documentation Video call with recording integrated into the clinical record Video call with recording integrated into the clinical record Clinical report available online Clinical report available online Table 12Requirements for the patient or caregiver Availability of internet/data connectionComputer/device/phone with camera and microphoneValid e-mail addressValid phone number Patients should be able to access the telemedicine system. The skills of the patient for using the telemedicine prescriptions should be assessed for each patient in relation to:the patient’s or caregiver’s ability to access technological systems that meet at least the minimum technical requirements for the correct and safe delivery of the service;the minimum competencies and skills that the patient must possess in order to appropriately use technological platforms;the patient’s adherence to the activation of the telemedicine service;the suitability and training of the patient or caregiver;the adequacy of the social aspects of the family context; andthe structural suitability of the home and clinical setting, also in relation to the use of equipment. Requirements for the patient or caregiver Availability of internet/data connection Availability of internet/data connection Computer/device/phone with camera and microphone Computer/device/phone with camera and microphone Valid e-mail address Valid e-mail address Valid phone number Valid phone number the patient’s or caregiver’s ability to access technological systems that meet at least the minimum technical requirements for the correct and safe delivery of the service; the patient’s or caregiver’s ability to access technological systems that meet at least the minimum technical requirements for the correct and safe delivery of the service; the minimum competencies and skills that the patient must possess in order to appropriately use technological platforms; the minimum competencies and skills that the patient must possess in order to appropriately use technological platforms; the patient’s adherence to the activation of the telemedicine service; the patient’s adherence to the activation of the telemedicine service; the suitability and training of the patient or caregiver; the suitability and training of the patient or caregiver; the adequacy of the social aspects of the family context; and the adequacy of the social aspects of the family context; and the structural suitability of the home and clinical setting, also in relation to the use of equipment. the structural suitability of the home and clinical setting, also in relation to the use of equipment. Table 13In-hospital phase pathway Patient referral and evaluation of social/family context, in-hospital clinical pathway, and ongoing therapy Assignment to a nurse case manager Definition of shared goals (patient–nurse–specialist) Allocation of tele-monitoring devices and education on their use Personalized alert settings and, for wearable devices, definition of monitoring duration and control frequency Identification of dedicated time slots for staff reviewing transmitted data Data sharing may include the patient’s GP depending on the pathology monitored Evaluation of the need for other specialists and non-medical professionals Notification to community care coordination centres (COT) of patient enrolment Scheduling of the first televisit (heart failure) or remote device control and in-person visits In-hospital phase pathway Patient referral and evaluation of social/family context, in-hospital clinical pathway, and ongoing therapy Patient referral and evaluation of social/family context, in-hospital clinical pathway, and ongoing therapy Assignment to a nurse case manager Assignment to a nurse case manager Definition of shared goals (patient–nurse–specialist) Definition of shared goals (patient–nurse–specialist) Allocation of tele-monitoring devices and education on their use Allocation of tele-monitoring devices and education on their use Personalized alert settings and, for wearable devices, definition of monitoring duration and control frequency Personalized alert settings and, for wearable devices, definition of monitoring duration and control frequency Identification of dedicated time slots for staff reviewing transmitted data Identification of dedicated time slots for staff reviewing transmitted data Data sharing may include the patient’s GP depending on the pathology monitored Data sharing may include the patient’s GP depending on the pathology monitored Evaluation of the need for other specialists and non-medical professionals Evaluation of the need for other specialists and non-medical professionals Notification to community care coordination centres (COT) of patient enrolment Notification to community care coordination centres (COT) of patient enrolment Scheduling of the first televisit (heart failure) or remote device control and in-person visits Scheduling of the first televisit (heart failure) or remote device control and in-person visits Table 14Extra-hospital phase pathway Tele-assistance May be managed by nursing staff Supports early symptom recognition and device/app management, identifies barriers to adherence (e.g. drug side effects) Verifies adequacy of physical therapy intensity Facilitates communication with physiotherapists, GPs, specialists, pharmacists Enables family involvement in the patient educational plan Tele-monitoring Level 1 (wearable devices) Transmission of clinical parameters (body weight, heart rate, blood pressure, etc.) In relation to wearable devices, parameter measurement may be performed independently by the patient or may involve home-based monitoring carried out by nurses equipped with tele-monitoring kits, with particular attention to the patients’ general condition, the presence of symptoms, adherence to therapy, and trends in the variation of the monitored parameters. Tele-monitoring Level 2 (implantable devices: PM, ICD, loop recorder, CardioMEMS) Identification of dedicated staff and time slots for reviewing transmissions Definition of alerts requiring physician notification Assignment of dedicated DRG Streamlined administrative procedures for reporting monitoring activities DRG, diagnosis-related groups; GP, general practitioner; ICD, implantable cardioverter-defibrillator; PM, pacemaker. Extra-hospital phase pathway May be managed by nursing staff May be managed by nursing staff Supports early symptom recognition and device/app management, identifies barriers to adherence (e.g. drug side effects) Supports early symptom recognition and device/app management, identifies barriers to adherence (e.g. drug side effects) Verifies adequacy of physical therapy intensity Verifies adequacy of physical therapy intensity Facilitates communication with physiotherapists, GPs, specialists, pharmacists Facilitates communication with physiotherapists, GPs, specialists, pharmacists Enables family involvement in the patient educational plan Enables family involvement in the patient educational plan Transmission of clinical parameters (body weight, heart rate, blood pressure, etc.) Transmission of clinical parameters (body weight, heart rate, blood pressure, etc.) In relation to wearable devices, parameter measurement may be performed independently by the patient or may involve home-based monitoring carried out by nurses equipped with tele-monitoring kits, with particular attention to the patients’ general condition, the presence of symptoms, adherence to therapy, and trends in the variation of the monitored parameters. In relation to wearable devices, parameter measurement may be performed independently by the patient or may involve home-based monitoring carried out by nurses equipped with tele-monitoring kits, with particular attention to the patients’ general condition, the presence of symptoms, adherence to therapy, and trends in the variation of the monitored parameters. Identification of dedicated staff and time slots for reviewing transmissions Identification of dedicated staff and time slots for reviewing transmissions Definition of alerts requiring physician notification Definition of alerts requiring physician notification Assignment of dedicated DRG Assignment of dedicated DRG Streamlined administrative procedures for reporting monitoring activities Streamlined administrative procedures for reporting monitoring activities DRG, diagnosis-related groups; GP, general practitioner; ICD, implantable cardioverter-defibrillator; PM, pacemaker. Occasional contact may be requested by the patient according to agreed modalities. It must never be used for emergencies, where calling 112 is mandatory. It is important for early symptom recognition or management of drug-related issues. Sharing among all professionals involved in the pathway is essential for achieving common goals and monitoring adherence (e.g. sharing electrophysiology reports for patients with implantable devices). Reassessment of the goals: Goals defined during the hospital phase may be achieved and require redefinition. What the recipient would like to read The GP perspective Some preambles are needed: Within the integrated inter-disciplinary management of the patients, a good communication and sharing of news and data between specialists and general practitioners is the cornerstone in the self-care process and management of the hospital-territory care continuity; in the context of hospital discharge, a clear and exhaustive paper or electronic discharge letter is essential for the comprehension, sharing, and security. Within the integrated inter-disciplinary management of the patients, a good communication and sharing of news and data between specialists and general practitioners is the cornerstone in the self-care process and management of the hospital-territory care continuity; in the context of hospital discharge, a clear and exhaustive paper or electronic discharge letter is essential for the comprehension, sharing, and security. Achievement, functioning, and the daily use of electronic health record might solve many criticisms in the transmission of data, thus making the discharge letter an adjunctive tool, which is useful for the engagement of the patients in the care plans. As per the health electronic record (HER), similar to a shared clinical database in which data are included in real time by physicians who are involved in the care of the patient, we can overcome the problem of data transfer and the need for updating therapeutic advice and follow-up indication in the general management software of general practitioners. Achievement, functioning, and the daily use of electronic health record might solve many criticisms in the transmission of data, thus making the discharge letter an adjunctive tool, which is useful for the engagement of the patients in the care plans. As per the health electronic record (HER), similar to a shared clinical database in which data are included in real time by physicians who are involved in the care of the patient, we can overcome the problem of data transfer and the need for updating therapeutic advice and follow-up indication in the general management software of general practitioners. The discharge letter should include the following: The discharge diagnosis or diagnoses with explicit specification of the International Classification of Diseases-9. The discharge diagnosis or diagnoses with explicit specification of the International Classification of Diseases-9. The patient’s clinical status at discharge and body weight at admission and at discharge is also useful (especially for patients with heart failure). The patient’s clinical status at discharge and body weight at admission and at discharge is also useful (especially for patients with heart failure). Diagnostic tests and treatments performed during hospitalization. Diagnostic tests and treatments performed during hospitalization. The pharmacological and non-pharmacological therapies proposed for any newly diagnosed conditions and any changes, with the corresponding rationale. The pharmacological and non-pharmacological therapies proposed for any newly diagnosed conditions and any changes, with the corresponding rationale. Follow-up instructions including the parameters to be monitored, the evaluations to be performed, and the proposed frequency. Follow-up instructions including the parameters to be monitored, the evaluations to be performed, and the proposed frequency. Indications regarding warning signs or the presence of a clinical condition that may require prompt intervention and management of complications. Indications regarding warning signs or the presence of a clinical condition that may require prompt intervention and management of complications. Any new care needs (incontinence aids, walking aids, etc., with the relevant prescriptions or the need for complex care settings); identification of frail patients or those at high risk of rehospitalization and indication to initiate home care, highlighting which interventions are a priority; this type of activation often presents difficulties or delays, as well as the frequent need for the involvement, in addition to the GP, of nurses and physiotherapists; it is therefore important that hospital wards are familiar with local services and organizational structures in order to avoid proposing care pathways and requests that cannot be fulfilled. Any new care needs (incontinence aids, walking aids, etc., with the relevant prescriptions or the need for complex care settings); identification of frail patients or those at high risk of rehospitalization and indication to initiate home care, highlighting which interventions are a priority; this type of activation often presents difficulties or delays, as well as the frequent need for the involvement, in addition to the GP, of nurses and physiotherapists; it is therefore important that hospital wards are familiar with local services and organizational structures in order to avoid proposing care pathways and requests that cannot be fulfilled. Identification of patients requiring palliative care, specifying the level of assistance required, in order to assess at the time of protected discharge, which needs the community is able to take on or whether there are conditions indicating transfer to a hospice or a long-term care facility. Identification of patients requiring palliative care, specifying the level of assistance required, in order to assess at the time of protected discharge, which needs the community is able to take on or whether there are conditions indicating transfer to a hospice or a long-term care facility. Contact details of the ward physicians who followed the patient, for any requests for information from the GP, with the possibility of direct communication channels for clarification, without having to go through the patient or family members. Contact details of the ward physicians who followed the patient, for any requests for information from the GP, with the possibility of direct communication channels for clarification, without having to go through the patient or family members. Furthermore, it would be useful if the discharge card contained specific information about the clinical follow-up pathways that the patients should follow, above all in case of individuals who were discharged after acute coronary syndrome, heart failure, atrial fibrillation, or other cardiovascular diseases. The discharge letter is still the main tool that guarantees the continuity in the care of patients. We believe that the early widespread of the HER would be the cornerstone for the correct management of information about clinical status of the patients by assuring immediate access, standardized data, and the best integration between hospital and territory. To invest resources in the digitalization of the national health system would certainly improve communication among physicians and further offer patients the most efficacious, shared, personalized, and safest care pathway. The patient’s perspective That being a physician is a job, is not in question. A job like any other one with a routine and a thousand habits, with hectic moments and others of calm, phases of difficulty, and moments of tranquility. During the day, it may happen that colleagues exchange a few jokes, that there is gaiety, or friction, perhaps an argument. That being a physician is a job with its everyday different features and aspects. To be carried out with conscientiousness and professionalism, but one in which thoughts and concerns from personal life inevitably intrude, just as thoughts and concerns from the working day end up going home. A job, in short. And yet this job has particular characteristics that make it somewhat different from all the others. Because it has to do with people’s lives, who, when they come into contact with these professionals, find themselves at a moment of immense difficulty and enormous importance. In many cases, at a true crossroad. The people who are the object of this profession are often facing a radical change in their existence. Nothing will ever be the same again, in any case. This is why, at the time of discharge, when one is about to leave behind this terrible phase of life, a patient must in no way feel like part of a routine. There is no comfort in being pigeonholed into an ordinary case history; a shared misfortune is no consolation at all, not even halfway. It is at the moment of discharge that a person needs their doctor. On that particular occasion, fear is greater. One is no longer monitored, no longer observed in the course of the illness, no longer the object of professionals’ attention. One will not be able to rely on immediate, reassuring urgent interventions; there is no bell to call for help, at night there will be no attentive nurses ready to support any need. One is left alone, and the main difficulty will be to observe oneself and understand how one actually feels. The fear is not understanding the signals of one’s own body—whether they are the usual ones, the ordinary ones that were there before, or whether they are alarm bells, warnings from the body of a new crisis, perhaps lethal, perhaps unmanageable. One finds oneself facing a new, unknown fragility. With the awareness that it will not be as before and that one must therefore come to terms with a new condition. The boundary between reassurance and minimization, we realize, is very thin. On one hand one would like to return to a normal life and that is what one is often told, but one also knows that it was precisely the previous life, often excessive ways and wrong behaviours, that brought them where they are; therefore no, one cannot be exactly as one was, one must change, but without feeling disabled, without carrying fears and indecision along. An explanation of the therapies will certainly be useful; medications are a new fact, the patient trusts them and they are a protective factor; knowing what they are for, what function they have, helps a great deal. And behavioural instructions—what must be paid attention to and to which signals—will be an important comfort, a constant reference. More than anything else, however, the smile will matter. There is no other moment in which one has more need of friendship, of closeness, even of affection. Nothing fake, nothing imposed. More than professionalism, more than competence will be necessary to feel that the doctor who puts you back into the world is on your side. Even if they remain in that place of suffering and yet reassuring, that smile will be the element patients carry home and remember when they find themselves alone, facing the visible and invisible wounds. A smile. That’s all. Models of discharge letters with follow-up timing according to disease The proposed documents are concise templates that include the main recommendations for continuation of care and secondary prevention measures, based on the contribution of multiple healthcare professionals involved in patient management, care, and treatment. The Panel considered it appropriate to focus on the cardiovascular diseases of greatest relevance in terms of prevalence, mortality, and hospitalization rates: ischaemic heart disease and heart failure, as well as hospital admissions related to cardiac pacing and electrophysiological procedures. The principal clinical characteristics, the determinants influencing recurrences/exacerbations and rehospitalizations, and the therapeutic targets are briefly described, with the aim of optimizing follow-up, improving continuity-of-care pathways, and positively influencing prognosis. Acute coronary syndrome Predictors of new coronary events64-66 have been identified in multi-vessel coronary artery disease, female gender, diabetes mellitus, heart failure, advanced age, and obstructive sleep apnoea syndrome. Achieving therapeutic targets represents the main objective to reduce ‘residual cardiovascular risk’.65 Residual risk and main therapeutic targets Arterial hypertension Hypertension induces endothelial dysfunction, dysregulation of the autonomic nervous system, and impaired vasoreactivity.67 European guidelines recommend, in secondary prevention, blood pressure values <130/80 mmHg. Dyslipidaemia LDL levels <55 mg/dL are recommended in patients with ischaemic heart disease (<40 mg/dL in very-high-risk categories and in case of recurrent ischaemic events), with initiation of high-intensity lipid-lowering therapy already during hospitalization, followed by the addition of non-statin lipid-lowering agents (ezetimibe, bempedoic acid, or PCSK9 inhibitors) if the target is not achieved.68 Cases of hypertriglyceridaemia should be reported, with possible indication for treatment. Diabetes mellitus Diabetic patients often present multi-vessel disease and multiple coronary lesions, a higher prevalence of unstable atherosclerotic plaques, and altered microvascular reactivity.69 The therapeutic goal is to maintain glycated haemoglobin <7%, with adjustments according to patient age. Smoking Smoking cessation reduces the risk of recurrent myocardial infarction or cardiovascular death by 30–50% over the subsequent 3–7 years.70 Chronic kidney disease These patients have a higher burden of comorbidities, endothelial dysfunction, inflammatory and pro-thrombotic states, and anaemia,71 as well as incomplete revascularization and sub-optimal therapeutic optimization.72 Main recommendations for the discharge letter Include the main pre-existing risk factors (including unfavourable psychosocial conditions and/or stress), those not at target, and ‘residual’ risk factors (in-hospital complications, residual coronary stenosis, reduced ejection fraction, and prescription contraindications), as well as corrective interventions proposed by the MDT. Pharmacological therapy should be clearly and comprehensibly described. It is suggested to list medications in chronological order of intake (including the active ingredient name) to improve adherence and reduce medication errors. Patients should be referred to follow-up programmes and CR when indicated (Supplementary figure 1). Patient with heart failure Several factors contribute to the high mortality, hospitalization, and 30-day rehospitalization rates characterizing heart failure.73-75 Demographic and socio-economic characteristics Heart failure with reduced ejection fraction is more prevalent in men, whereas heart failure with preserved ejection fraction is more frequent in women.76 Low socio-economic status is associated with reduced quality of care, limited access to community services, and consequently lower treatment adherence and medication titration.77 Comorbidities Diabetes mellitus is present in ∼40% of patients and is an independent predictor of new hospitalizations.78,79 Chronic obstructive pulmonary disease,80 present in about 30% of heart failure patients, contributes to right ventricular overload and dysfunction. Renal failure promotes oxidative stress, endothelial dysfunction, volume overload, electrolyte imbalance, release of uraemic toxins, and anaemia.81,82 Anaemia increases hospitalization risk,83,84 and treatment—particularly of iron deficiency anaemia—improves functional capacity.84 Main recommendations for the discharge letter Highlight precipitating factors and risk factors that may predispose to clinical destabilization; assign the patient to a nurse case manager where available; enrol in structured follow-up programmes specifying the optimal timing for the first control visit; and refer to CR pathways when indicated. Provide a clear list of prescribed medications, preferably in chronological order of intake, and schedule—or indicate—titration in terms of timing, dosage, and need for clinical reassessment (Supplementary figure 2). Patient undergoing electrostimulation/electrophysiology procedures Provide the patient, the GP, and other specialists with a description of the procedures performed and their indications regarding the underlying disease, the clinical course, and any complications. The models of implanted devices and the related electronic parameters should be specified. Clearly state the therapeutic indications and recommendations the patient must follow for recovery, follow-up, and ongoing care, including pre-arranged appointments and visits (Supplementary figure 3). Specific conditions Cognitive decline, dementia, frailty, and multi-morbidity represent negative prognostic determinants, influencing therapeutic adherence, continuity of care, regularity of follow-up, and the burden on family members/caregivers. Caregiver involvement is essential and should be identified early. Key recommendations for caregivers include the following: Involvement in the care team. Involvement in the care team. Provision of clear and accurate information about the disease. Provision of clear and accurate information about the disease. Connection with the support service network before discharge. Connection with the support service network before discharge. Information about the follow-up programme.85 Information about the follow-up programme.85 The discharge letter should report episodes of disorientation, aggression, or delirium occurring during hospitalization, the specific treatments administered, and the planning of specialist follow-up to be conducted remotely (telephone or virtual) for less complex cases, reserving direct in-person care for more complex situations. The increasing proportion of elderly patients is associated with frailty, multi-morbidity, cognitive impairment, polypharmacy, and disability; therefore, a multidisciplinary intervention is necessary and more effective.86 Frailty87 complicates disease progression, with higher rates of delirium, prolonged hospitalization, post-operative complications, and need for institutionalization after discharge. Routine assessment of frailty and comorbidity burden is essential (Table 15). The contribution of all dedicated healthcare professionals and the involvement of family members/caregivers are necessary for medication management and verification, planning of clinical and instrumental follow-up, and the use of remote visits (telemedicine). In selected cases, the patient may be eligible for CR pathways.88 Table 15Frail patient and/or patients with multiple morbiditiesPhenotypeClinical descriptionVery fitRobust, active individuals, full of energy and motivated. They exercise regularly and are among the most active for their age.FitNo active disease or symptoms, but less fit than the previous category. They are physically active occasionally, often depending on the season.Managing wellDo not engage in regular physical activity apart from walking for daily activities. Medical problems are well controlled.VulnerableNot dependent on others, but symptoms limit daily life. They feel tired and slowed down during the day. Illness is often not well controlled.Mildly frailNeed help with more demanding daily activities (transportation, heavy housework, managing finances, and medication management).Moderately frailTotally dependent for more complex daily activities and also require help with basic activities (personal hygiene, dressing, and climbing stairs).Severely frailCompletely dependent in all activities of daily living. Clinically stable and not at high risk of death within the next 6 months.Very severely frailCompletely dependent on others. End of life is approaching. Recovery is not possible even from minor illness.Description of the frail patient phenotype. In moderately and severely frail individuals, cognitive decline and/or depression are frequently associated conditions. Frail patient and/or patients with multiple morbidities Description of the frail patient phenotype. In moderately and severely frail individuals, cognitive decline and/or depression are frequently associated conditions. The approach to patients with cognitive impairment and dementia should be structured and multidisciplinary (Table 16). Table 16Components of care for patients with cognitive impairment or dementia DiagnosisOngoing assessment and reassessmentCare planningMedical managementInformation provision, education, and informed and supported decision-makingRecognition and emotional support for the person with dementiaCare for the person with dementia, including assessment of impairment in basic activities of daily livingInvolvement, emotional support, and assistance for family members/caregiversPrevention and management of behavioural and psychological symptoms of dementiaSafety for the person with dementia, including evaluation of physical and social environmental modificationsCare transitions from hospital to home or residential facilities, considering the needs of the patient and family/caregivers Components of care for patients with cognitive impairment or dementia Diagnosis Diagnosis Ongoing assessment and reassessment Ongoing assessment and reassessment Care planning Care planning Medical management Medical management Information provision, education, and informed and supported decision-making Information provision, education, and informed and supported decision-making Recognition and emotional support for the person with dementia Recognition and emotional support for the person with dementia Care for the person with dementia, including assessment of impairment in basic activities of daily living Care for the person with dementia, including assessment of impairment in basic activities of daily living Involvement, emotional support, and assistance for family members/caregivers Involvement, emotional support, and assistance for family members/caregivers Prevention and management of behavioural and psychological symptoms of dementia Prevention and management of behavioural and psychological symptoms of dementia Safety for the person with dementia, including evaluation of physical and social environmental modifications Safety for the person with dementia, including evaluation of physical and social environmental modifications Care transitions from hospital to home or residential facilities, considering the needs of the patient and family/caregivers Care transitions from hospital to home or residential facilities, considering the needs of the patient and family/caregivers Conclusions An updated discharge model characterized by practical operational references, grounded in the most recent scientific evidence and supported by the multidisciplinary expertise that works alongside the clinical cardiologist, is essential to ensure that discharge represents a central element in improving the care pathway. This pathway begins at the time of hospital admission and is therefore an integral part of the patient’s care process. The discharge letter must include all essential information for the GP in a clear and accessible format, so as to be useful not only to the physician but also to the patient and family members or caregivers. It thus becomes a fundamental tool for the transmission of information concerning the entire hospitalization. Table 17 summarizes the essential contents of the discharge letter. Table 17Essential elements that must always be included in the discharge letterItemContent1 Identification of the hospital facility, discharging unit, and its staff 2 Place and date of document preparation 3 Patient identification 4 Date of admission and date of discharge 5 Discharge diagnosis 6 Reason for admission 7 Diagnostic, interventional, or surgical procedures performed, with brief description 8 Hospital course, including clinical evolution, diagnostic–therapeutic pathway, rehabilitation or care pathway; post-operative course in case of surgery 9 Patient’s clinical condition at discharge 10 Functional status at discharge and care needs 11 Pharmacological prescriptions: drug type, dosage, and duration of treatment 12 Non-pharmacological prescriptions: diet, physical activity, home self-monitoring 13 Follow-up instructions 14 Date and modality of access for the first post-discharge visit 15 Cardiac rehabilitation pathway, with indications 16 Name and signature of the responsible physician and collaborating non-medical professionals Essential elements that must always be included in the discharge letter Identification of the hospital facility, discharging unit, and its staff Identification of the hospital facility, discharging unit, and its staff Place and date of document preparation Place and date of document preparation Patient identification Patient identification Date of admission and date of discharge Date of admission and date of discharge Discharge diagnosis Discharge diagnosis Reason for admission Reason for admission Diagnostic, interventional, or surgical procedures performed, with brief description Diagnostic, interventional, or surgical procedures performed, with brief description Hospital course, including clinical evolution, diagnostic–therapeutic pathway, rehabilitation or care pathway; post-operative course in case of surgery Hospital course, including clinical evolution, diagnostic–therapeutic pathway, rehabilitation or care pathway; post-operative course in case of surgery Patient’s clinical condition at discharge Patient’s clinical condition at discharge Functional status at discharge and care needs Functional status at discharge and care needs Pharmacological prescriptions: drug type, dosage, and duration of treatment Pharmacological prescriptions: drug type, dosage, and duration of treatment Non-pharmacological prescriptions: diet, physical activity, home self-monitoring Non-pharmacological prescriptions: diet, physical activity, home self-monitoring Follow-up instructions Follow-up instructions Date and modality of access for the first post-discharge visit Date and modality of access for the first post-discharge visit Cardiac rehabilitation pathway, with indications Cardiac rehabilitation pathway, with indications Name and signature of the responsible physician and collaborating non-medical professionals Name and signature of the responsible physician and collaborating non-medical professionals Supplementary Material